共 43 条
- [41] Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2016, 31 (06) : 1163 - 1168
- [42] Is Pathologic Complete Response a Good Predictor for the Long-Term, Clinical Outcome in Patients with Gastric Cancer After Neoadjuvant Chemotherapy? A Retrospective, Multi-institution Study in China (Jun, 10.1245/s10434-023-13728-5, 2023) ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (09) : 5563 - 5563
- [43] Phase II study of primary systemic therapy (PST) with doxorubicin (D) and docetaxel (T), then surgery (S), and radiation (RT), followed by use of non-cross-resistant adjuvant chemotherapy (Adj CT) with CMF based on pathologic response, in patients (pts) with locally advanced breast cancer (LABC): Long-term results from study ID97-099, M. D. Anderson Cancer Center JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)